Search

Shardul D. Patel

Examiner (ID: 9227, Phone: (571)270-7758 , Office: P/3662 )

Most Active Art Unit
3662
Art Unit(s)
3662, 3661, 3665, 3664
Total Applications
954
Issued Applications
810
Pending Applications
65
Abandoned Applications
99
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
08/164022 PROCESS FOR GENERATING SPECIFIC ANTIBODIES Dec 7, 1993 Abandoned
08/154389 CDR GRAFTED ANTI-CEA ANTIBODIES AND THEIR PRODUCTION Nov 16, 1993 Abandoned
08/143908 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS Oct 25, 1993 Abandoned
Array ( [id] => 3828493 [patent_doc_number] => 05783671 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Method and composition for preparation of factor VIIIC' [patent_app_type] => 1 [patent_app_number] => 8/143527 [patent_app_country] => US [patent_app_date] => 1993-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8120 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783671.pdf [firstpage_image] =>[orig_patent_app_number] => 143527 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/143527 		Method and composition for preparation of factor VIIIC Oct 25, 1993 Issued
08/143498 METHODS AND COMPOSITIONS FOR HIGH PROTIEN PRODUCTION FROM NON-NATIVE DNA Oct 24, 1993 Abandoned
08/135877 CANCER IMMUNOTHERAPY WITH ANTIBODIES TO CANCER PROCOAGULANT Oct 12, 1993 Abandoned
08/134869 MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR MEMBRANE-ASSOCIATED ANTIGENS Oct 11, 1993 Abandoned
Array ( [id] => 3609687 [patent_doc_number] => 05534254 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-09 [patent_title] => 'Biosynthetic binding proteins for immuno-targeting' [patent_app_type] => 1 [patent_app_number] => 8/133804 [patent_app_country] => US [patent_app_date] => 1993-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 15464 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/534/05534254.pdf [firstpage_image] =>[orig_patent_app_number] => 133804 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/133804 		Biosynthetic binding proteins for immuno-targeting Oct 6, 1993 Issued
08/134556 GENETICALLY ENGINEERED BISPECIFIC TETRAVALENT ANTIBODIES Oct 6, 1993 Abandoned
08/124469 GRAVES' OPHTHALMOPATHY ASSOCIATED ANTIBODIES, GRAVES' OPHTHALMOPATHY ORBITAL ANTIGEN, AND METHODS OF USE THEREOF Sep 21, 1993 Abandoned
Array ( [id] => 3510745 [patent_doc_number] => 05512283 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-30 [patent_title] => 'Methods for the selective suppression of an immune response to dust mite der Pi' [patent_app_type] => 1 [patent_app_number] => 8/123746 [patent_app_country] => US [patent_app_date] => 1993-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 47 [patent_no_of_words] => 24277 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/512/05512283.pdf [firstpage_image] =>[orig_patent_app_number] => 123746 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/123746 		Methods for the selective suppression of an immune response to dust mite der Pi Sep 15, 1993 Issued
Array ( [id] => 3559334 [patent_doc_number] => 05502168 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-26 [patent_title] => 'Monoclonal antibodies to a continuous and cross-reactive epitope and an isolated protein of a sexual stage of P. falciparum' [patent_app_type] => 1 [patent_app_number] => 8/120225 [patent_app_country] => US [patent_app_date] => 1993-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 7651 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/502/05502168.pdf [firstpage_image] =>[orig_patent_app_number] => 120225 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/120225 		Monoclonal antibodies to a continuous and cross-reactive epitope and an isolated protein of a sexual stage of P. falciparum Sep 13, 1993 Issued
08/118692 REGULATION OF CELL PROLIFERATION AND DIFFERENTIATION USING PEPTIDES Sep 9, 1993 Abandoned
08/116882 PURIFIED MAMMALIAN CTLA-4 LIGANDS AND RELATED REAGENTS Sep 2, 1993 Abandoned
08/106944 IMMUNOGLOBULINS DEVOID OF LIGHT CHAINS Aug 16, 1993 Abandoned
08/101341 HYBRIDOMA GROWTH FACTOR AND USE THEREOF Aug 1, 1993 Abandoned
Array ( [id] => 3635872 [patent_doc_number] => 05610279 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Human TNF receptor' [patent_app_type] => 1 [patent_app_number] => 8/095640 [patent_app_country] => US [patent_app_date] => 1993-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 12518 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610279.pdf [firstpage_image] =>[orig_patent_app_number] => 095640 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/095640 		Human TNF receptor Jul 20, 1993 Issued
Array ( [id] => 3101188 [patent_doc_number] => 05314996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-24 [patent_title] => 'Isolated nucleotide sequences encoding an: antigen binding site of monoclonal antibody PD41; and antigen associated with prostate adenocarcinomas' [patent_app_type] => 1 [patent_app_number] => 8/091628 [patent_app_country] => US [patent_app_date] => 1993-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 12073 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/314/05314996.pdf [firstpage_image] =>[orig_patent_app_number] => 091628 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/091628 		Isolated nucleotide sequences encoding an: antigen binding site of monoclonal antibody PD41; and antigen associated with prostate adenocarcinomas Jul 12, 1993 Issued
08/076071 CD28 PATHWAY IMMUNOSUPPRESSION Jun 9, 1993 Pending
08/073223 METHODS FOR SELECTIVITY STIMULATING PROLIFERATION OF T-CELLS Jun 3, 1993 Pending
Menu